Osocimab for VTE Prevention After TKA, Changes in FDA Approval and Regulation of Pharmaceuticals, Neuropsych Testing of Older Clinicians Prior to Recredentialing, and more
JAMA Editors' Summary · American Medical Association
January 14, 202012m 18s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 14, 2020 issue